Correlation Between Achilles Therapeutics and Vincerx Pharma
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Vincerx Pharma, you can compare the effects of market volatilities on Achilles Therapeutics and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Vincerx Pharma.
Diversification Opportunities for Achilles Therapeutics and Vincerx Pharma
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Achilles and Vincerx is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Vincerx Pharma go up and down completely randomly.
Pair Corralation between Achilles Therapeutics and Vincerx Pharma
Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.13 times more return on investment than Vincerx Pharma. However, Achilles Therapeutics PLC is 7.44 times less risky than Vincerx Pharma. It trades about -0.03 of its potential returns per unit of risk. Vincerx Pharma is currently generating about -0.53 per unit of risk. If you would invest 114.00 in Achilles Therapeutics PLC on November 3, 2024 and sell it today you would lose (1.00) from holding Achilles Therapeutics PLC or give up 0.88% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Achilles Therapeutics PLC vs. Vincerx Pharma
Performance |
Timeline |
Achilles Therapeutics PLC |
Vincerx Pharma |
Achilles Therapeutics and Vincerx Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Achilles Therapeutics and Vincerx Pharma
The main advantage of trading using opposite Achilles Therapeutics and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
Vincerx Pharma vs. Spero Therapeutics | Vincerx Pharma vs. Bolt Biotherapeutics | Vincerx Pharma vs. Coherus BioSciences | Vincerx Pharma vs. Applied Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |